Radiolabelled peptides in diagnosis and therapy: an introduction.

摘要

The emergence of peptide receptor radionuclide imaging (PRRI) is highly regarded as a landmark in the diagnosis of tumours and other diseases through interaction with cell membrane receptors. The small size and low molecular weight of peptides, compared to proteins and antibodies, facilitate rapid access to target tissue and similarly, fast clearance from nontarget tissue.